PETROS PHARMACEUTICALS, INC.

Profile

Company Names

PETROS PHARMACEUTICALS, INC.

Addresses

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY 10036

1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY 10036

Phone Numbers

973-242-0005
(973) 242-0005

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$35,740,029.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-07-13 
$30,000,006.00 
$30,000,006.00 
$0.00 
Equity 
3
2021-12-22 
$2,200,023.00 
$8,324,820.00 
$6,124,797.00 
Equity 
2
2021-11-29 
$3,540,000.00 
$12,815,000.00 
$9,275,000.00 
Equity 
1
2021-10-13 
$0.00 
$5,922,951.00 
$5,922,951.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MITCHELL 
 
ARNOLD 
EXECUTIVE OFFICER
PETROS PHARMACEUTICALS, INC.
BRUCE 
T. 
BERNSTEIN 
DIRECTOR
ROCKMORE GLOBAL (US), LP   |  SYNAPTOGENIX, INC.   |  PETROS PHARMACEUTICALS, INC.
FADY 
 
BOCTOR 
EXECUTIVE OFFICER
PETROS PHARMACEUTICALS, INC.
GREGORY 
 
BRADLEY 
DIRECTOR
PETROS PHARMACEUTICALS, INC.   |  CRAFT3
ANDREW 
 
GESEK 
EXECUTIVE OFFICER
ACCENSIONE INVESTMENT PARTNERS LLC   |  SELME LLC   |  PETROS PHARMACEUTICALS, INC.
JOHN 
D. 
SHULMAN 
DIRECTOR
JWC ACQUISITION CORP.   |  JUGGERNAUT CAPITAL PARTNERS II, L.P.   |  JUGGERNAUT ASM COINVESTMENT, L.P.   |  JUGGERNAUT CAPITAL PARTNERS III, L.P.   |  JUGGERNAUT FOUNDATION COINVESTMENT, L.P.   |  JUGGERNAUT CAPITAL PARTNERS IV-A, L.P.   |  JUGGERNAUT CAPITAL PARTNERS IV-B, L.P.   |  METUCHEN PHARMACEUTICALS, LLC   |  JUGGERNAUT ASM COINVESTMENT II, L.P.   |  JUGGERNAUT BCH COINVESTMENT, L.P.   |  PETROS PHARMACEUTICALS, INC.   |  JUGGERNAUT KSM COINVESTMENT, L.P.
JOSHUA 
N. 
SILVERMAN 
DIRECTOR
IROQUOIS CAPITAL LP   |  IROQUOIS CAPITAL OFFSHORE LTD   |  SYNAPTOGENIX, INC.   |  PETROS PHARMACEUTICALS, INC.   |  PHARMACYTE BIOTECH, INC.
WAYNE 
R. 
WALKER 
DIRECTOR
AYRO, INC.   |  PETROS PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-21
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-13 
2022-01-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2021-12-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-29 
2021-10-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-10-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
KATALYST SECURITIES LLC
112494